Large-scale production and purification of biological compounds
生物化合物的大规模生产和纯化
基本信息
- 批准号:7593413
- 负责人:
- 金额:$ 30.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AdsorptionBacillus anthracisBacteriaBedsBiochemistryBiologicalBiotechnologyCell DensityCellsCells Plant TissueCommercial SourcesCorynebacterium diphtheriaeDevelopmentEngineeringEscherichia coliFermentationG-Protein-Coupled ReceptorsG-substrateGenus staphylococcusGrowthHela CellsHumanImmunotoxinsInfluenzaInsectaLaboratory ResearchMaintenanceMammalian CellMethodsMicrobiologyMolecular BiologyNational Institute of Diabetes and Digestive and Kidney DiseasesNumbersOperative Surgical ProceduresPichiaPolysaccharidesPreparationProcessProductionProteinsPseudomonas aeruginosa toxA proteinRangeRecombinant ProteinsRecombinantsRecoveryResearchResearch Project GrantsSaccharomyces cerevisiaeSalmonellaSourceT-Cell DepletionTissuesVaccinesYeastsadiponectincancer typedrug developmentinstrumentationmicroorganismstructural biology
项目摘要
A significant portion of the Units activities is the production of high-quality and unique biologicals that are not available from commercial sources. On average, the Unit performs between 150 to 200 processes per year, which include fermentation of bacteria, yeast, insect cells, and mammalian cells (in volumes ranging from 2 to 200 liters), and recovery and purification of biomolecules, such as proteins and polysaccharides, from different sources. The following are examples of processes performed: growth of bacteria like Escherichia coli, (recombinant and native), Corynebacteria diphtheria, Salmonella, Shighella, Staphylococcus, Haefmofillus influenzae, Bacillus Anthracis, and various recombinant yeast strains like Saccharomyces cerevisiae and Pichia pastoris. In addition, mammalian cells such as HeLa, CHO, BHK and HEK 293, and insect cells like Sf 9, and High five for transient expression of recombinant proteins were propagated. Several proteins were produced and purified in gram quantities. Examples are: recombinant Pseudomonas aeruginosa exotoxin A, and human adiponectin.
The various products were needed for a number of collaborative research projects: the preparation of immunotoxins for the treatment of specific types of cancer and T cell depletion, human adiponectin was made for biological studies and several proteins were produced for structural studies among them Toll proteins and G protein-coupled receptors.
该单位的一项重要活动是生产商业来源无法获得的高质量和独特的生物制剂。平均而言,该单位每年进行150至200个过程,其中包括细菌,酵母,昆虫细胞和哺乳动物细胞的发酵(体积从2到200升不等),以及从不同来源回收和纯化生物分子,如蛋白质和多糖。以下是进行的过程的实例:细菌如大肠杆菌(重组和天然)、白喉棒状杆菌、沙门氏菌、斯海氏菌、葡萄球菌、流感嗜血杆菌、炭疽芽孢杆菌和各种重组酵母菌株如酿酒酵母和巴斯德毕赤酵母的生长。此外,繁殖哺乳动物细胞如HeLa、CHO、BHK和HEK 293,以及昆虫细胞如Sf 9和High five,用于瞬时表达重组蛋白。几种蛋白质的生产和纯化克量。例如:重组铜绿假单胞菌外毒素A和人脂联素。
许多合作研究项目都需要各种产品:制备用于治疗特定类型癌症和T细胞消耗的免疫毒素,为生物学研究制备人脂联素,并为结构研究生产了几种蛋白质,其中包括Toll蛋白和G蛋白偶联受体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph Shiloach其他文献
Joseph Shiloach的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph Shiloach', 18)}}的其他基金
Large-scale production and purification of biological compounds
生物化合物的大规模生产和纯化
- 批准号:
9356265 - 财政年份:
- 资助金额:
$ 30.26万 - 项目类别:
Production , purification and preparation of various candidiate vaccines
各种候选疫苗的生产、纯化和制备
- 批准号:
8741643 - 财政年份:
- 资助金额:
$ 30.26万 - 项目类别:
Identification of genes related to spcific properties of mammalian cells
与哺乳动物细胞特定特性相关的基因的鉴定
- 批准号:
10697827 - 财政年份:
- 资助金额:
$ 30.26万 - 项目类别:
Identification of genes related to spcific properties of mammalian cells
与哺乳动物细胞特定特性相关的基因的鉴定
- 批准号:
10250250 - 财政年份:
- 资助金额:
$ 30.26万 - 项目类别:
Large-scale production and purification of biological compounds
生物化合物的大规模生产和纯化
- 批准号:
9148972 - 财政年份:
- 资助金额:
$ 30.26万 - 项目类别:
Large-scale production and purification of biological compounds
生物化合物的大规模生产和纯化
- 批准号:
8554134 - 财政年份:
- 资助金额:
$ 30.26万 - 项目类别:
Identification of genes realted to spcific properties of mammlian cells
与哺乳动物细胞特定特性相关的基因的鉴定
- 批准号:
7967773 - 财政年份:
- 资助金额:
$ 30.26万 - 项目类别:
相似海外基金
Development of a novel anthrax vaccine utilizing capsule biosynthesis protein CapA of Bacillus anthracis
利用炭疽杆菌荚膜生物合成蛋白CapA开发新型炭疽疫苗
- 批准号:
23K19460 - 财政年份:2023
- 资助金额:
$ 30.26万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Identification and characterization of a comprehensive set of factors required for sporulation and germination in Bacillus anthracis
炭疽芽孢杆菌孢子形成和萌发所需的一系列综合因素的鉴定和表征
- 批准号:
10510204 - 财政年份:2022
- 资助金额:
$ 30.26万 - 项目类别:
Identification and characterization of a comprehensive set of factors required for sporulation and germination in Bacillus anthracis
炭疽芽孢杆菌孢子形成和萌发所需的一系列综合因素的鉴定和表征
- 批准号:
10632069 - 财政年份:2022
- 资助金额:
$ 30.26万 - 项目类别:
Task A08: In Vitro Bacillus anthracis Lethal Toxin Neutralization Assay for Assessment of 5 Anti-Lethal Factor VHH Clones
任务 A08:用于评估 5 个抗致死因子 VHH 克隆的体外炭疽杆菌致死毒素中和测定
- 批准号:
10078441 - 财政年份:2019
- 资助金额:
$ 30.26万 - 项目类别:
Bio-imaging of the Bacillus anthracis spore coat
炭疽芽孢杆菌孢子衣的生物成像
- 批准号:
1945401 - 财政年份:2017
- 资助金额:
$ 30.26万 - 项目类别:
Studentship
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis
针对炭疽杆菌的感染部位靶向抗毒素抗体 (ISTAb)
- 批准号:
10199998 - 财政年份:2017
- 资助金额:
$ 30.26万 - 项目类别:
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis
针对炭疽杆菌的感染部位靶向抗毒素抗体 (ISTAb)
- 批准号:
9973142 - 财政年份:2017
- 资助金额:
$ 30.26万 - 项目类别:
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis
针对炭疽杆菌的感染部位靶向抗毒素抗体 (ISTAb)
- 批准号:
10817474 - 财政年份:2017
- 资助金额:
$ 30.26万 - 项目类别:
Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis
针对炭疽杆菌的感染部位靶向抗毒素抗体 (ISTAb)
- 批准号:
9255053 - 财政年份:2017
- 资助金额:
$ 30.26万 - 项目类别:
Molecular epidemiology of Bacillus anthracis: Novel data and techniques for surveillance in endemic settings
炭疽杆菌的分子流行病学:流行环境监测的新数据和技术
- 批准号:
471750-2015 - 财政年份:2017
- 资助金额:
$ 30.26万 - 项目类别:
Postdoctoral Fellowships














{{item.name}}会员




